The amino acid transporter SLC6A15 is a regulator of hippocampal neurochemistry and behavior

Journal of Psychiatric Research

Volumn 68, Issue , 2015, Pages 261-269

  Santarelli, Sara ^a   Namendorf, Christian ^a   Anderzhanova, Elmira ^a   Gerlach, Tamara ^a   Bedenk, Benedikt ^a   Kaltwasser, Sebastian ^a   Wagner, Klaus ^a   Labermaier, Christiana ^a   Reichel, Judith ^a   Drgonova, Jana ^b   Czisch, Michael ^a   Uhr, Manfred ^a   Schmidt, Mathias V ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Behavior; Glutamate; Hippocampus; Translational psychiatry

Indexed keywords

AMINO ACID; AMINO ACID TRANSPORTER; GLUTAMIC ACID; GLUTAMINE; PROLINE; PROTEIN SLC6A15; UNCLASSIFIED DRUG; SLC6A15 PROTEIN, MOUSE;

AMINO ACID BRAIN LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN TISSUE; CONTROLLED STUDY; ENDOPHENOTYPE; FOREBRAIN; GLUTAMATERGIC TRANSMISSION; HIPPOCAMPUS; MALE; MENTAL DISEASE; MOUSE; NEUROCHEMISTRY; NEUROTRANSMISSION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR; SENSORY GATING; ANATOMY AND HISTOLOGY; ANIMAL; ANIMAL BEHAVIOR; C57BL MOUSE; CHEMISTRY; GENETICS; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

AMINO ACID TRANSPORT SYSTEMS, NEUTRAL; ANIMALS; BEHAVIOR, ANIMAL; GLUTAMIC ACID; HIPPOCAMPUS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROLINE; REAL-TIME POLYMERASE CHAIN REACTION; SENSORY GATING; SIGNAL TRANSDUCTION;

EID: 84937920519     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2015.07.012     Document Type: Article

References (37)

1. Barbeito L., Siciliano J., Dajas F. Depletion of the Ca(++)-dependent releasable pool of glutamate in striatal synaptosomes associated with dendrotoxin-induced potassium channel blockade. J.Neural Transm. Gen. Sect. 1990, 80:167-179.
2. Baxter C.F., Baldwin R.A., Davis J.L., Flood J.F. High proline levels in the brains of mice as related to specific learning deficits. Pharmacol. Biochem. Behav. 1985, 22:1053-1059.
3. Braff D.L. Sensorimotor gating and schizophrenia. Arch. Gen. Psychiatry. American Medical Association 1990, 47:181.
4. Bröer A., Tietze N., Kowalczuk S., Chubb S., Munzinger M., Bak L.K., et al. The orphan transporter v7-3 (slc6a15) is a Na+-dependent neutral amino acid transporter (B0AT2). Biochem. J. 2006, 393:421-430.
5. Chen G., Henter I.D., Manji H.K. Presynaptic glutamatergic dysfunction in bipolar disorder. Biol. Psychiatry 2010, 67:1007-1009.
6. Cherkin A., Eckardt M., Gerbrandt L. Memory: proline induces retrograde amnesia in chicks. Science 1976, 193:242-244.
7. Cohen S.M., Nadler J.V. Proline-induced potentiation of glutamate transmission. Brain Res. 1997, 761:271-282.
8. Delwing D., Bavaresco C.S., Wannmacher C.M.D., Wajner M., Dutra-Filho C.S., Wyse A.T.S. Proline induces oxidative stress in cerebral cortex of rats. Int. J. Dev. Neurosci. 2003, 21:105-110.
9. Drgonova J., Liu Q.-R., Hall F.S., Krieger R.M., Uhl G.R. Deletion of v7-3 (SLC6A15) transporter allows assessment of its roles in synaptosomal proline uptake, leucine uptake and behaviors. Brain Res. 2007, 1183:10-20.
10. George Paxinos K.F. Paxinos and Franklin's the Mouse Brain in Stereotaxic Coordinates [Internet] 2012, Acad. Press, São Paulo.
11. Geyer M., Krebs-Thomson K., Braff D., Swerdlow N. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacol. Berl. 2001, 156:117-154.
12. Gogos J.a., Santha M., Takacs Z., Beck K.D., Luine V., Lucas L.R., et al. The gene encoding proline dehydrogenase modulates sensorimotor gating in mice. Nat. Genet. 1999, 21:434-439.
13. Grünecker B., Kaltwasser S.F., Peterse Y., Sämann P.G., Schmidt M.V., Wotjak C.T., et al. Fractionated manganese injections: effects on MRI contrast enhancement and physiological measures in C57BL/6 mice. NMR Biomed. 2010, 23:913-921.
14. Gustavsson A., Svensson M., Jacobi F., Allgulander C., Alonso J., Beghi E., et al. Cost of disorders of the brain in Europe 2010. Eur. Neuropsychopharmacol. 2011, 21:718-779.
15. Hägglund M.G.a., Roshanbin S., Löfqvist E., Hellsten S.V., Nilsson V.C.O., Todkar A., et al. B(0)AT2 (SLC6A15) is localized to neurons and astrocytes, and is involved in mediating the effect of leucine in the brain. PLoS One 2013, vol. 8:e58651. Public Library of Science.
16. Henzi V., Reichling D., Helm S., MacDermott A. L-proline activates glutamate and glycine receptors in cultured rat dorsal horn neurons. Mol. Pharmacol. 1992, 41:793-801.
17. Kao C.-Y., Stalla G., Stalla J., Wotjak C.T., Anderzhanova E. Norepinephrine and corticosterone in the medial prefrontal cortex and hippocampus predict PTSD-like symptoms in mice. Eur. J. Neurosci. 2015, 41:1139-1148. 10.1111/ejn.12860.
18. Kohli M.A., Lucae S., Saemann P.G., Schmidt M.V., Demirkan A., Hek K., et al. The neuronal transporter gene SLC6A15 confers risk to major depression. Neuron 2011, 70:252-265.
19. Labermaier C., Kohl C., Hartmann J., Devigny C., Altmann A., Weber P., et al. Apolymorphism in the Crhr1 gene determines stress vulnerability in male mice. Endocrinol. Endocrine Society Chevy Chase, MD 2014, 155:2500-2510.
20. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
21. Lopez A.D., Mathers C.D., Ezzati M., Jamison D.T.M.C. The Burden of Disease and Mortality by Condition: Data, Methods, and Results for 2001 [Internet] 2006, World Bank.
22. Moghaddam B., Javitt D. From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment. Neuropsychopharmacology 2012, 37:4-15.
23. Moreira J.F., Wannmacher C.M.D., Costa S.M., Wajner M. Effect of proline administration on rat behavior in aversive and nonaversive tasks. Pharmacol. Biochem. Behav. 1989, 32:885-890.
24. Moussawi K., Riegel A., Nair S., Kalivas P.W. Extracellular glutamate: functional compartments operate in different concentration ranges. Front. Syst. Neurosci. 2011, 5:94.
25. Nusbaum M.P., Contreras D. Sensorimotor gating: startle submits to presynaptic inhibition. Curr. Biol. 2004, 14:R247-R249.
26. Pérez-Arellano I., Carmona-Alvarez F., Martínez A.I., Rodríguez-Díaz J., Cervera J. Pyrroline-5-carboxylate synthase and proline biosynthesis: from osmotolerance to rare metabolic disease. Protein Sci. 2010, 19:372-382.
27. Reynolds L.M., Cochran S.M., Morris B.J., Pratt J.A., Reynolds G.P. Chronic phencyclidine administration induces schizophrenia-like changes in N-acetylaspartate and N-acetylaspartylglutamate in rat brain. Schizophr. Res. 2005, 73:147-152.
28. Riedel G., Platt B., Micheau J. Glutamate receptor function in learning and memory. Behav. Brain Res. 2003, 140:1-47.
29. Rodríguez M.J., Robledo P., Andrade C., Mahy N. Invivo co-ordinated interactions between inhibitory systems to control glutamate-mediated hippocampal excitability. J.Neurochem. 2005, 95:651-661.
30. Roussos P., Giakoumaki S.G., Bitsios P. Arisk PRODH haplotype affects sensorimotor gating, memory, schizotypy, and anxiety in healthy male subjects. Biol. Psychiatry. Society of Biological Psychiatry 2009, 65:1063-1070.
31. Rozen S., Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol. Biol. 2000, 132:365-386.
32. Sanacora G., Treccani G., Popoli M. Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology 2012, 62:63-77.
33. Schmidt M.V., Schülke J.-P., Liebl C., Stiess M., Avrabos C., Bock J., et al. Tumor suppressor down-regulated in renal cell carcinoma 1 (DRR1) is a stress-induced actin bundling factor that modulates synaptic efficacy and cognition. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:17213-17218.
34. Schuhmacher A., Lennertz L., Wagner M., Höfels S., Pfeiffer U., Guttenthaler V., et al. Avariant of the neuronal amino acid transporter SLC6A15 is associated with ACTH and cortisol responses and cognitive performance in unipolar depression. Int. J. Neuropsychopharmacol. 2013, 16:83-90.
35. Smith S., Sharp T. Measurement of GABA in rat brain microdialysates using o-phthaldialdehyde-sulphite derivatization and high-performance liquid chromatography with electrochemical detection. J.Chromatogr. B Biomed. Sci. Appl. 1994, 652(2):228-233.
36. Tebartz van Elst L., Maier S., Fangmeier T., Endres D., Mueller G.T., Nickel K., et al. Disturbed cingulate glutamate metabolism in adults with high-functioning autism spectrum disorder: evidence in support of the excitatory/inhibitory imbalance hypothesis. Mol. Psychiatry 2014, 19:1314-1325.
37. Yen Y.-C., Anderzhanova E., Bunck M., Schuller J., Landgraf R., Wotjak C.T. Co-segregation of hyperactivity, active coping styles, and cognitive dysfunction in mice selectively bred for low levels of anxiety. Front. Behav. Neurosci. 2013, 7:103.